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Abstract
Previous studies have shown that herpes simplex virus type 1 (HSV-1) replication is inhibited by the
cyclin-dependent kinase (cdk) inhibitor roscovitine. One roscovitine-sensitive cdk that functions in
neurons is cdk5, which is activated in part by its binding partner, p35. Because HSV establishes latent
infections in sensory neurons, we sought to determine the role p35 plays in HSV-1 replication in
vivo. For these studies, wild-type (wt) and p35-/- mice were infected with HSV-1 using the mouse
ocular model of HSV latency and reactivation. The current results indicate that p35 is an important
determinant of viral replication in vivo.
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Introduction
Herpes simplex virus type 1 (HSV-1) is a prevalent human pathogen that causes cold sores and
is the leading cause of infectious blindness in western industrialized countries (Fields et al,
2007). Upon infection at a peripheral site, HSV-1 undergoes lytic replication and ultimately
establishes a latent infection in sensory neurons, which can reactivate from latency upon
physical or emotional stress. The molecular mechanisms that lead to the establishment of
latency and promote reactivation are largely unknown.
Cyclin-dependent kinases (cdks) are cellular factors involved in the cell cycle and are critical
determinants as to whether an HSV infection will be lytic or remain latent. To date at least 13
cdks have been described (Malumbres and Barbacid, 2009). Several cdk inhibitors block
progression at the G1/S and G2/M boundaries of the cell cycle. Notably, two cdk inhibitors,
roscovitine (rosco) and olomoucine (olo), also inhibit HSV-1 replication by blocking viral
transcription, viral DNA replication, and reactivation (Schang et al, 1998, 1999, 2000, 2002).
One roscovitine-sensitive cdk of interest is cdk5, a serine/threonine kinase that regulates
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neuronal positioning during brain development (Ohshima et al, 1996) and modulates
intracellular transport in neurons (Smith and Tsai, 2002).
Cdk5 activity is, in large part, regulated by p35 or its cleaved form, p25; both proteins act as
specific activators of cdk5 (Lew et al, 1994; Tsai et al, 1994). p35 has been reported to localize
primarily in the cytoplasm and/or cell membrane of neurons (Nikolic et al, 1996, 1998;
Ohshima et al, 1996). Coexpression of cdk5 and p35 leads cdk5 to localize to p35-containing
cellular compartments, suggesting that the subcellular location of cdk5 is influenced by p35,
putting cdk5 in close proximity with several of its substrates. p35 knockout mice display a
reverse packing order of cortical neurons during brain development, leading to cortical
lamination defects and a low level of sporadic adult seizures and lethality (Chae et al, 1997).
Cdk5 activity is also regulated by a related isoform of p35, known as p39 (Tang and Wang,
1996). It has been shown that cdk5 activity is important for survival, as mice lacking both p35
and p39 show a high degree of embryonic lethality (Ko et al, 2001). p35-/- mice are viable;
thus, it is not known whether there exists a specific subset of cdk5 that is uniquely activated
by p35 or if the observable phenotypes in p35-/- mice are simply a result of an overall lower
level of cdk5 activity. Because cdk5 is important in several neuronal processes and is a
roscovitine-sensitive cdk, we hypothesized that a lack of p35 would result in diminished viral
replication. To initially test this hypothesis, we infected wild-type (wt) and p35-/- mice ocularly
with HSV-1 and monitored viral replication and reactivation in vivo.
Results
To determine whether p35 contributes to viral shedding in the eyes, 6- to 8-week-old p35-/-
(Chae et al, 1997)) and wt (C57BL/6) mice were infected with wt HSV-1 (strain KOS) at 1 ×
105 plaque-forming units (PFU) per eye, and eye swabs were taken on days 1, 3, 5, and 7 post
infection (p.i.). As shown in Figure 1, the HSV-1 titers were reduced in p35-/- mice on days 3
and 5 p.i. 12-fold and 9-fold, respectively, relative to C57BL/6 mice (P = .0095 on day 3 and
P = .0005 on day 5, unpaired t test). On days 1 and 7 p.i., viral titers were similar or marginally
affected between the two mouse strains. Viral shedding was at or near the limit of detection
on day 7 p.i., as has been previously reported for wt mice (Halford et al, 2004). We observed
that ocular titers for both strains of mice did not exceed input inoculum levels. Two published
reports, however, indicate that de novo viral replication was being measured in our experiments,
as opposed to viral clearance (Leib et al, 1989; Strelow and Leib, 1995). Our results indicate
that p35 is necessary for efficient viral shedding in the eyes.
We then examined acute viral replication in neurons of the trigeminal ganglia (TG) of ocularly
infected mice on days 1, 3, 5, and 7 p.i. Results from these experiments (Figure 2) showed that
viral growth was decreased 16-fold by day 3 p.i. and 17-fold by day 5 p.i. when p35-/- TG
titers were compared to those of C57BL/6 mice (P = .0003 and P = .0002, respectively, unpaired
t test). Viral replication was similar between the two groups on days 1 and 7 p.i. TG titers in
wt mice on day 7 approached the limit of detection, which has been reported by others (Jung
et al, 2004).
To assess the capability of HSV-1 to establish latency in the two different mouse strains, viral
DNA loads were determined by real-time polymerase chain reaction (PCR) from latently
infected TG 30 days p.i. As shown in Figure 3, there was an 8.3-fold decrease in latent HSV-1
genomes present in p35-/- TG compared to wt TG (P = .001, unpaired t test).
To determine whether this decrease in establishing a latent infection affected viral reactivation,
explant cultures were done with latently infected wt and p35-/- TG 30 days p.i. and cocultured
on Vero cells (Link and Schaffer, 2007). In these assays, HSV-1 reactivated from 100% of wt
mice TG by day 5, whereas only 25% of p35-/- day mice TG reactivated by 5 (Figure 4), which
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was statistically significant (P = .0013, Fisher’s exact test). Prior to heat shock treatment, only
33% of p35-/- the TG had reactivated; efficiency of reactivation increased to 58% in the p35-/-
strain by day 15 post explant.
Discussion
The results of this study indicate that p35 is required for efficient HSV-1 replication in mice
and suggest that HSV-1 utilizes cdk5 activity to promote high levels of viral growth. Consistent
with our results, one report showed that cdk5 and p35 are coexpressed in adult mouse corneal
epithelium (Gao et al, 2002). Cdk5 has been reported to play roles in the adhesion, migration,
and differentiation of lens and corneal epithelial cells (reviewed in Rosales and Lee, 2006).
Clearly, the absence of p35 significantly diminished acute ocular replication. Thus, HSV-1
appears to take advantage of the non-neuronal functions of cdk5 and p35 to facilitate efficient
shedding in the eyes of mice.
Acute viral replication was also reduced in the TG of p35-/- mice. It is known that viral
replication in the eyes can influence productive replication in the TG (Leib et al, 1989).
However, at least one published report supports the hypothesis that the reduction in TG titers
we observed in p35-/- mice cannot be solely attributable to reductions in HSV-1 ocular
shedding. This study showed that maximal ocular and TG titers for wt HSV-1 are
approximately the same in vivo, although TG titers peak 2 days later than the ocular titers
(Thompson et al, 2009). Given that there was a minor decrease (<3-fold) in the peak of p35-/-
ocular titers on day 1 p.i., this decrease alone cannot account for the significant reduction (16-
fold) in the peak of p35-/- TG titers on day 3 p.i. Taken together, these results strongly suggest
that p35 plays a role in enhancing lytic infection in sensory neurons. This decrease in acute
replication in p35-/- neurons appears to have reduced the ability of HSV-1 to establish an
efficient latent infection (an 8.3-fold decrease), which consequently can impact reactivation.
The reductions in acute TG replication and viral latency in p35-/- mice are consistent with the
model that the level of viral DNA replication in TG neurons during acute infection determines
how efficiently HSV-1 can establish a latent infection (Coen et al, 1989; Katz et al, 1990;
Kosz-Vnenchak et al, 1990; Sawtell et al, 2006). Although not within the confines of this initial
report, future experiments will be needed to establish equivalent latent infections in both mouse
strains in order to determine whether p35 is required for efficient reactivation. A role for p35
and cdk5 in reactivation is very plausible given that one study showed the cdk inhibitor rosco
blocked HSV-1 antigen expression and explant-induced reactivation in neurons (Schang et
al, 2002). Whether p35 has one or more functions independent of cdk5 in the mouse ocular
model of HSV latency remains to be determined.
The molecular mechanisms by which p35 and cdk5 facilitate HSV-1 productive infection have
not been determined. Given cdk5’s multiple activities, several possibilities exist, which are not
necessarily mutually exclusive. A recent publication has indicated that cdk5 appears to protect
neurons from cell death (Zhang et al, 2010). Consequently, p35 and cdk5 may prevent virally
induced apoptosis in a subset of acutely and/or latently infected neurons. Because cdk5 plays
a role in trafficking (Smith and Tsai, 2002), a decrease in cdk5 activity due to a lack of p35
could impair the transport of viral nucleocapsids or proteins via microtubule-associated motors,
especially in neurons. In addition to transport, cdk5 and p35 have been reported to translocate
into the nuclei of neurons (Ino and Chiba, 1996; Qu et al, 2002), phosphorylate, and alter the
activity of cellular transcription factors such as MEF2, p53, and Stat3 (Fu et al, 2004; Gong
et al, 2003; Lee et al, 2007), which may activate viral gene expression. Moreover, roscovitine-
sensitive cdks have been shown to alter the posttranslational modification states of several
HSV-1 regulatory proteins (e.g., ICP0, ICP4, ICP22) (Advani et al, 2001; Schang et al,
1999), and in the case of ICP0 and ICP4, these modifications have been linked to their
transcriptional activities (Davido et al, 2002; Schang et al, 1999). Whether an indirect or direct
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effect, the lack of p35 could diminish the transcription of HSV-1 genes, impairing viral
replication. Additional studies will address these potential mechanisms.
Methods
Infection of mice
Animals were handled according to the Guide for the Care and Use of Laboratory Animals
(National Research Council, 1996). wt (C57BL/6; The Jackson Laboratories and Charles River
Laboratories) and p35-/- mice (a gift from Dr. L.H. Tsai, Harvard Medical School [Chae et
al, 1997]) were anesthetized, and their corneas scarified and bilaterally infected with wt HSV-1
(strain KOS) at 1 × 105 plaque-forming units (PFU) per eye in 3 μl as previously described
(Balliet and Schaffer, 2006).
Acute ocular and trigeminal ganglia titers
Eye swabs were taken on days 1, 3, 5, and 7 post infection (p.i.) as previously published (Balliet
and Schaffer, 2006), using a cotton-tipped applicator to collect tear film from each eye. Each
trigeminal ganglion from an infected mouse was harvested on days 1, 3, 5, and 7 p.i., and frozen
and homogenized as described (Balliet and Schaffer, 2006). Viral titers for samples were
determined by standard plaque assays on Vero cells (Schaffer et al, 1973).
Latent viral DNA loads
DNA was isolated by phenol chloroform extraction from TG (Halford and Schaffer, 2000) of
latently infected mice 30 days p.i., and real-time PCR was performed by amplifying two
specific genes: relative HSV-1 genome loads were determined using primers specific for the
UL50 gene (sequences courtesy of Dr. Lynda Morrison, St. Louis University) and normalized
against the mouse adipsin gene (Strand and Leib, 2004).
Ex vivo reactivation
Reactivation assays were carried out as described by Link and Schaffer (Link and Schaffer,
2007). Briefly, each explanted trigeminal ganglion was cut into eight pieces and placed into a
well of a 24-well plate seeded with 3 × 104 Vero cells in 1.5 ml of Dulbecco’s modified Eagle’s
medium (DMEM) containing 5% fetal bovine serum. Every 24 h, 150 μl of medium was
removed from each sample and monitored for cytopathic effect on a Vero cell mono-layer. On
day 10 post explantation, cells were heat shocked at 43°C for 3 h as an additional stimulus for
reactivation. Sampling was continued until day 15 post explantation.
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HSV-1 ocular shedding in p35-/- mice. C57BL/6 and p35-/- mice were ocularly infected with
1 × 105 PFU/eye, and eye swabs were taken on days 1, 3, 5, and 7 post infection (p.i.). Viral
titers of eye swabs (n = 8 per time point) were determined by standard plaque assays. Results
displayed are logarithmic means, with error bars showing the standard error of the means
(SEMs). The horizontal stippled line represents the lower limit of detection. Results from one
experiment are shown; similar results were observed in a repeat experiment.
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Acute viral replication in murine TG. TG from C57BL/6 and p35-/- infected mice were
removed days 1, 3, 5, and 7 p.i., and TG homogenates were titered by standard plaque assays
(n = 8 per time point). The results displayed are logarithmic means, with the error bars
representing the SEMs. The horizontal stippled line represents the lower limit of detection.
Results from one experiment are shown; similar results were observed in a repeat experiment.
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Latent viral DNA loads in wt and p35-/- mice. TG were removed from C57BL/6 and p35-/-
latently infected mice at 30 days p.i., and DNA was isolated from each TG. The relative
establishment of HSV-1 latency for each mouse strain (n = 14 per group) was determined by
real-time PCR using primers that amplified the HSV-1 UL50 gene. UL50 gene levels were
normalized to a DNA loading control, the mouse adipsin gene. Data shown are logarithmic
(base 2) means. Error bars represent SEMs. Mockinfected samples were below the limit of
detection for the UL50 gene (data not shown).
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HSV-1 reactivation in latently infected TG. On days 30 p.i., TG were removed from C57BL/
6 and p35-/- latently infected mice and explanted on Vero cells. Medium from each sample
was monitored daily for infectious virus over a period of 15 days (n = 8 for C57BL/6, n = 12
for p35-/-). The arrow at the top of the figure (day 10 post explant) indicates that samples were
heat shocked at 43°C for 3 h to induce further reactivation. The results from one of two
experiments are shown. The percent reactivation is the cumulative amount of reactivation for
each set of samples analyzed.
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